Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18077033rdf:typepubmed:Citationlld:pubmed
pubmed-article:18077033lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:18077033lifeskim:mentionsumls-concept:C1522449lld:lifeskim
pubmed-article:18077033lifeskim:mentionsumls-concept:C0460148lld:lifeskim
pubmed-article:18077033lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:18077033lifeskim:mentionsumls-concept:C1268086lld:lifeskim
pubmed-article:18077033lifeskim:mentionsumls-concept:C0178602lld:lifeskim
pubmed-article:18077033lifeskim:mentionsumls-concept:C0678226lld:lifeskim
pubmed-article:18077033lifeskim:mentionsumls-concept:C0729296lld:lifeskim
pubmed-article:18077033lifeskim:mentionsumls-concept:C0301630lld:lifeskim
pubmed-article:18077033lifeskim:mentionsumls-concept:C0521115lld:lifeskim
pubmed-article:18077033lifeskim:mentionsumls-concept:C0205284lld:lifeskim
pubmed-article:18077033pubmed:issue3lld:pubmed
pubmed-article:18077033pubmed:dateCreated2008-6-18lld:pubmed
pubmed-article:18077033pubmed:abstractTextTo quantify potential benefits of CTV-to-PTV margin reduction for SBRT of liver tumours, as allowed by enhanced treatment precision.lld:pubmed
pubmed-article:18077033pubmed:languageenglld:pubmed
pubmed-article:18077033pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18077033pubmed:citationSubsetIMlld:pubmed
pubmed-article:18077033pubmed:statusMEDLINElld:pubmed
pubmed-article:18077033pubmed:monthJunlld:pubmed
pubmed-article:18077033pubmed:issn0167-8140lld:pubmed
pubmed-article:18077033pubmed:authorpubmed-author:CalandrinoRic...lld:pubmed
pubmed-article:18077033pubmed:authorpubmed-author:HeijmenBenBlld:pubmed
pubmed-article:18077033pubmed:authorpubmed-author:Méndez...lld:pubmed
pubmed-article:18077033pubmed:authorpubmed-author:WunderinkWout...lld:pubmed
pubmed-article:18077033pubmed:authorpubmed-author:CattaneoMauro...lld:pubmed
pubmed-article:18077033pubmed:authorpubmed-author:MolinelliSilv...lld:pubmed
pubmed-article:18077033pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:18077033pubmed:issnTypePrintlld:pubmed
pubmed-article:18077033pubmed:volume87lld:pubmed
pubmed-article:18077033pubmed:ownerNLMlld:pubmed
pubmed-article:18077033pubmed:authorsCompleteYlld:pubmed
pubmed-article:18077033pubmed:pagination432-8lld:pubmed
pubmed-article:18077033pubmed:meshHeadingpubmed-meshheading:18077033...lld:pubmed
pubmed-article:18077033pubmed:meshHeadingpubmed-meshheading:18077033...lld:pubmed
pubmed-article:18077033pubmed:meshHeadingpubmed-meshheading:18077033...lld:pubmed
pubmed-article:18077033pubmed:meshHeadingpubmed-meshheading:18077033...lld:pubmed
pubmed-article:18077033pubmed:meshHeadingpubmed-meshheading:18077033...lld:pubmed
pubmed-article:18077033pubmed:meshHeadingpubmed-meshheading:18077033...lld:pubmed
pubmed-article:18077033pubmed:meshHeadingpubmed-meshheading:18077033...lld:pubmed
pubmed-article:18077033pubmed:meshHeadingpubmed-meshheading:18077033...lld:pubmed
pubmed-article:18077033pubmed:year2008lld:pubmed
pubmed-article:18077033pubmed:articleTitleSimultaneous tumour dose escalation and liver sparing in Stereotactic Body Radiation Therapy (SBRT) for liver tumours due to CTV-to-PTV margin reduction.lld:pubmed
pubmed-article:18077033pubmed:affiliationDepartment of Radiation Oncology, Erasmus MC - Daniel den Hoed Cancer Center, Rotterdam, The Netherlands. silvia.molinelli@pv.infn.itlld:pubmed
pubmed-article:18077033pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18077033pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18077033lld:pubmed